Head of Investor Relations
Iqvia Holdings Inc. (IQV)Equibles does not estimate personal net worth.
Get an email with a short summary when Iqvia Holdings Inc. publishes a filing, an earnings call transcript or a press release.
Get IQV alertsNick Childs is recorded as Head of Investor Relations at Iqvia Holdings Inc. (IQV). Nick Childs has spoken on 7 earnings calls across 1 company, most recently for Iqvia Holdings Inc. on August 1, 2023. Iqvia Holdings Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Iqvia Holdings Inc. includes Michael J. Fedock (CFO), Keriann Cherofsky (Chief Accounting Officer), Ari Bousbib (Board Member) and 7 others.
“With me today are Ari Bousbib, Chairman and Chief Executive Officer; Ron Bruehlman, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Mike Fedock, Senior Vice President, Financial Planning and Analysis; and Gustavo Perrone, Senior Director, Investor…”
“With me today are Ari Bousbib, Chairman and Chief Executive Officer; Ron Bruehlman, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Mike Fedock, Senior Vice President, Financial Planning and Analysis; and Gustavo Param, Senior Director, Investor…”
“With me today are Ari Bousbib, Chairman and Chief Executive Officer; Ron Bruehlman, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Mike Fedock, Senior Vice President, Financial Planning and Analysis; and Gustavo Perrone, Senior Director, Investor…”
“With me today are Ari Bousbib, Chairman and Chief Executive Officer; Ron Bruehlman, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Mike Fedock, Senior Vice President, Financial Planning and Analysis; and Gustavo Perrone, Senior Director, Investor…”
“With me today are Ari Bousbib, Chairman and Chief Executive Officer; Ron Bruehlman, Executive Vice President and Chief Financial Officer; Eric Sherbet, Executive Vice President and General Counsel; Mike Fedock, Senior Vice President, Financial Planning and Analysis; and Bryan Stengel, Associate Director, Investor…”
Diagnostics & Research · Healthcare
Head of Investor Relations
